Vanberra Signal

CREmedical

Curated by Signal

Developer of medical device for brain monitoring

Overview

Developer of a medical device for brain monitoring brain for disorder diagnosis and treatment. The company's brain monitoring device "tEEG", uses the Tripolar Concentric Ring Electrodes (TCREs), to detect signals on the scalp’s surface. The tEEG system provides artifact suppression. High-frequency oscillations (HFOs) are considered the biomarkers for early seizure development and epileptogenic zone. The device offers a non-invasive method to detect HFOs from the scalp which can potentially help to predict when a person may have a seizure like those associated with epilepsy.

Key facts

Founded
2011

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Pharmacogenomic tests for cardiovascular drug response.

    Life Sciences TechnologyMinnetonka, United States
  • Provider of home base device for health monitoring and emergency or critical care

    Life Sciences TechnologyPortland, United States
  • Developer of a neurostimulation-based implant to restore hearing

    Life Sciences TechnologyMountain View, United States

About CREmedical

What does CREmedical do?

Developer of a medical device for brain monitoring brain for disorder diagnosis and treatment.

Where is CREmedical headquartered?

CREmedical is headquartered in South Kingstown, United States.

When was CREmedical founded?

CREmedical was founded in 2011.

Which sector is CREmedical in?

CREmedical operates in Life Sciences Technology.

Who are CREmedical's competitors?

Companies similar to CREmedical include Geneticure, ProMedix, and Auricle.